CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company
Corvus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CRVS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464670809
- Phone
- (650) 900-4520
- Business address
- 901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $50,475
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$50,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-09 | MILLER RICHARD A MD President and CEO | Purchase | +3,784 | $9.89 | $37K | 986,077 |
| 2017-06-08 | ADAMS STREET PARTNERS LLC 10% owner | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-08 | Gould Terry P Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-08 | Thompson Peter A. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-08 | Krognes Steve E. Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-08 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-06-08 | Morrison Scott W Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2017-01-03 | CLARK IAN T Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2016-12-07 | MILLER RICHARD A MD President and CEO | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2016-12-07 | Verner Erik J. V.P., Chemistry Research | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-12-07 | Jones William Benton VP Pharmaceutical Development | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-12-07 | LEA LEIV Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2016-06-24 | Thompson Peter A. Director | Purchase | +900 | $12.99 | $12K | 5,379,349 |
| 2016-06-24 | ORBIMED ADVISORS LLC Director | Purchase | +900 | $12.99 | $12K | 5,379,349 |
| 2016-06-23 | Thompson Peter A. Director | Purchase | +100 | $12.92 | $1K | 5,378,449 |
| 2016-06-23 | ORBIMED ADVISORS LLC Director | Purchase | +100 | $12.92 | $1K | 5,378,449 |
| 2016-06-21 | Thompson Peter A. Director | Purchase | +26,083 | $12.87 | $336K | 5,378,349 |
| 2016-06-21 | ORBIMED ADVISORS LLC Director | Purchase | +26,083 | $12.87 | $336K | 5,378,349 |
| 2016-06-17 | Thompson Peter A. Director | Purchase | +12,300 | $12.48 | $154K | 5,352,266 |
| 2016-06-17 | ORBIMED ADVISORS LLC Director | Purchase | +12,300 | $12.48 | $154K | 5,352,266 |
Page 14 of 19 · 371 trades